Disruption of DNA-methylation-dependent long gene repression in Rett syndrome

Nature

Volumn 522, Issue 7554, 2015, Pages 89-93

  Gabel, Harrison W ^a   Kinde, Benyam ^a   Stroud, Hume ^a   Gilbert, Caitlin S ^a   Harmin, David A ^a   Kastan, Nathaniel R ^a   Hemberg, Martin ^a,b   Ebert, Daniel H ^a   Greenberg, Michael E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A;

ABNORMALITY; BRAIN; DNA; GENE EXPRESSION; METHYLATION; NEUROLOGY; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL FUNCTION; CELL POPULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; REPRESSOR GENE; RETT SYNDROME; RNA SEQUENCE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION TERMINATION; ANIMAL; BRAIN; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NERVE CELL; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; BRAIN; DISEASE MODELS, ANIMAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NEURONS; RETT SYNDROME;

EID: 84928533445     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14319     Document Type: Article

References (53)

1. Chahrour, M. & Zoghbi, H. Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422-437 (2007).
2. Guy, J., Cheval, H., Selfridge, J. & Bird, A. The role ofMeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 27, 631-652 (2011).
3. Tudor, M., Akbarian, S., Chen, R. Z. & Jaenisch, R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA 99, 15536-15541 (2002).
4. Jordan, C., Li, H. H., Kwan, H. C.& Francke,U. Cerebellar gene expression profiles of mousemodels for Rett syndrome reveal novel MeCP2 targets.BMCMed. Genet. 8, 36 (2007).
5. Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224-1229 (2008).
6. Ben-Shachar, S., Chahrour, M.,Thaller, C., Shaw, C. A.&Zoghbi, H. Y.Mousemodels of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum. Mol. Genet. 18, 2431-2442 (2009).
7. Samaco, R. C. et al. Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nature Genet. 44, 206-211 (2012).
8. Baker, S. A. et al. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152, 984-996 (2013).
9. Zhao, Y. T., Goffin,D., Johnson,B.S.&Zhou, Z. Loss ofMeCP2functionis associated with distinct gene expression changes in the striatum. Neurobiol. Dis. 59, 257-266 (2013).
10. King, I. F. et al. Topoisomerases facilitate transcription of long genes linked to autism. Nature 501, 58-62 (2013).
11. Sugino, K. et al. Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes. J. Neurosci. 34, 12877-12883 (2014).
12. Meins,M. et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J. Med. Genet. 42, e12 (2005).
13. Collins, A. L. et al. Mild overexpression ofMeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679-2689 (2004).
14. Lyst, M. J. et al. Rett syndromemutations abolish the interaction ofMeCP2 with the NCoR/SMRT co-repressor. Nature Neurosci. 16, 898-902 (2013).
15. Li, Y. et al. Global transcriptional and translational repression in humanembryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13, 446-458 (2013).
16. Deng, V. et al. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum. Mol. Genet. 16, 640-650 (2007).
17. Lewis, J. D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-914 (1992).
18. Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S. & Heintz, N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430 (2012).
19. Guo, J. U. et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nature Neurosci. 17, 215-222 (2014).
20. Skene, P. J. et al. NeuronalMeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457-468 (2010).
21. Kriaucionis, S. & Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009).
22. Szulwach, K. E. et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nature Neurosci. 14, 1607-1616 (2011).
23. Xie,W. et al. Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell 148, 816-831 (2012).
24. Lister, R. et al. Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905 (2013).
25. Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72-85 (2011).
26. Kaneda, M. et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429, 900-903 (2004).
27. Polymenidou,M. et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature Neurosci. 14, 459-468 (2011).
28. Raychaudhuri, S. et al. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet. 6, e1001097 (2010).
29. Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261 (2011).
30. Yazdani, M. et al. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 30, 2128-2139 (2012).
31. McGill, R., Tukey, J. & Larsen, W. A. Variations of box plots. Am. Stat. 32, 12-16 (1978).
32. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
33. Kim, T. K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182-187 (2010).
34. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).
35. Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature Protocols 7, 562-578 (2012).
36. Wagner, G. P., Kin, K. & Lynch, V. J. Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples. Theory in Biosciences 131, 281-285 (2012).
37. Wu, Y., Genton, M. G. & Stefanski, L. A. A multivariate two-sample mean test for small sample size and missing data. Biometrics 62, 877-885 (2006).
38. Chen, P. Y., Cokus, S. J. & Pellegrini, M. B. S. Seeker: precise mapping for bisulfite sequencing. BMC Bioinformatics 11, 203 (2010).
39. Ebert, D. H. et al. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499, 341-345 (2013).
40. Feng, J., Liu, T. & Zhang, Y. Using MACS to identify peaks from ChIP-seq data. Current Protocols in Bioinformat. Chapter 2, Unit 2 14 (2011).
41. Nagy, G., Daniel, B., Jonas, D., Nagy, L. & Barta, E. A novel method to predict regulatory regions based on histone mark landscapes in macrophages. Immunobiology 218, 1416-1427 (2013).
42. Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nature Genet. 23, 99-103 (1999).
43. Chen, W. G. et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885-889 (2003).
44. Huang da.W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists usingDAVIDbioinformatics resources.Nature Protocols 4,44-57 (2009).
45. Brown, V. et al. Microarray identification of FMRP-Associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477-487 (2001).
46. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifyingmammalian transcriptomes by RNA-seq. Nature Methods 5, 621-628 (2008).
47. Gray, J. M. et al. SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample. PLoS ONE 9, e89673 (2014).
48. Tiscornia, G., Singer, O. & Verma, I. M. Production and purification of lentiviral vectors. Nature Protocols 1, 241-245 (2006).
49. Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activitydependentBdnf transcription, dendritic growth, and spinematuration. Neuron 52, 255-269 (2006).
50. Valinluck, V. et al. Oxidative damage to methyl-CpGsequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32, 4100-4108 (2004).
51. Hashimoto, H. et al. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 40, 4841-4849 (2012).
52. Spruijt, C.G. et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152, 1146-1159 (2013).
53. Khrapunov, S. et al. Unusual characteristics of the DNA binding domain of epigenetic regulatory protein MeCP2 determine its binding specificity. Biochemistry 53, 3379-3391 (2014).